| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMEA/775140/2009 (3.12.09) |
| Publication Date | 03/12/2009 |
| Content Type | News |
|
The European Medicines Agency (EMEA), on 3 December 2009, published the first in a series of weekly pandemic pharmacovigilance updates. The information on adverse reactions in the update comes from EudraVigilance, the central European database on adverse reactions, managed by the Agency. It is based on reports from Member States and marketing authorisation holders. Subsequent updates may be found on the Agency's Pandemic influenza (H1N1) website. (Please click on the Related Url and select weekly updates). |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2009/12/news_detail_000611.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
